Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

NCT02410603 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02410603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02410603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
December 31, 2016
Completion date
January 1, 2021
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, cancer of lung, cancer of the lung, carcinoma, non-small-cell lung, lung cancer, lung neoplasms, neoplasms, lung, neoplasms, pulmonary, pulmonary cancer, pulmonary neoplasms, squamous cell carcinoma